Page last updated: 2024-08-23

haloperidol decanoate and Akinetic-Rigid Variant of Huntington Disease

haloperidol decanoate has been researched along with Akinetic-Rigid Variant of Huntington Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Betuing, S; Brouillet, E; Caboche, J; Charvin, D; Déglon, N; Deyts, C; Luthi-Carter, R; Pagès, C; Perrin, V; Régulier, E; Roze, E	1

Other Studies

1 other study(ies) available for haloperidol decanoate and Akinetic-Rigid Variant of Huntington Disease

Article	Year
Haloperidol protects striatal neurons from dysfunction induced by mutated huntingtin in vivo. Neurobiology of disease, 2008, Volume: 29, Issue:1 Topics: Age Factors; Animals; Antipsychotic Agents; Cell Count; Corpus Striatum; Disease Models, Animal; Dopamine and cAMP-Regulated Phosphoprotein 32; Female; Gene Expression Regulation; Haloperidol; Huntingtin Protein; Huntington Disease; Lentivirus; Mutation; Nerve Tissue Proteins; Neurons; Nuclear Proteins; Phosphopyruvate Hydratase; Rats; Rats, Wistar	2008

Article

Year

Haloperidol protects striatal neurons from dysfunction induced by mutated huntingtin in vivo.

Neurobiology of disease, 2008, Volume: 29, Issue:1

Topics: Age Factors; Animals; Antipsychotic Agents; Cell Count; Corpus Striatum; Disease Models, Animal; Dopamine and cAMP-Regulated Phosphoprotein 32; Female; Gene Expression Regulation; Haloperidol; Huntingtin Protein; Huntington Disease; Lentivirus; Mutation; Nerve Tissue Proteins; Neurons; Nuclear Proteins; Phosphopyruvate Hydratase; Rats; Rats, Wistar

2008